BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+10.99%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.61B
AUM Growth
+$3.61B
(+10%)
Cap. Flow
+$56.8M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
74.41%
Holding
28
New
–
Increased
15
Reduced
4
Closed
1
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$29.3M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$25.7M |
| 3 |
Incyte
INCY
|
$17.9M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
$17.7M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$15.3M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$66.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12.9M |
| 3 |
CELG
Celgene Corp
CELG
|
$9.48M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$7.98M |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$5.83M |
Sector Composition
| 1 | Healthcare | 91.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novavax
NVAX
$1.2B
| $9.5M | 0.26% |
416,500
| – | – |
|
|
ACHN
27
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.74M | 0.16% |
1,279,340
| – | – |
|
|
KITE
28
DELISTED
Kite Pharma, Inc.
KITE
| – | – |
-640,000
| Closed | -$66.3M |
|